Stefan R. Vink

A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells

Arnold H. van der Luit, Stefan R. Vink, Jeffrey Klarenbeek et al. · Molecular Cancer Therapeutics · 2007 · 137 citations · Full text

Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours

Stefan R. Vink, Jan H.M. Schellens, Jos H. Beijnen et al. · Radiotherapy and Oncology · 2006 · 71 citations

Radiation Therapy, Medicine, Radionuclide Therapy +11

Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid

Stefan R. Vink, Jan H.M. Schellens, Wim J. van Blitterswijk et al. · Investigational New Drugs · 2005 · 66 citations

Oncology, Medicine, Oral Anti-cancer Alkylphospholipid +6

Enriching lipid nanovesicles with short‐chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors

Menno van Lummel, Wim J. van Blitterswijk, Stefan R. Vink et al. · The FASEB Journal · 2010 · 58 citations

Radiosensitization of Squamous Cell Carcinoma by the Alkylphospholipid Perifosine in Cell Culture and Xenografts

Stefan R. Vink, Saskia Lagerwerf, Elly Mesman et al. · Clinical Cancer Research · 2006 · 56 citations